SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-569496
Filing Date
2016-04-29
Accepted
2016-04-29 16:33:09
Documents
2
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d169636ddefa14a.htm DEFA14A 30139
2 GRAPHIC g169636g0429194815695.jpg GRAPHIC 3800
  Complete submission text file 0001193125-16-569496.txt   36772
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14956 | Film No.: 161607165
SIC: 2834 Pharmaceutical Preparations